Rain Oncology Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Rain Oncology Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2023.
- Rain Oncology Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$7.03M, a 61% increase year-over-year.
- Rain Oncology Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$72.3M, a 1.73% decline year-over-year.
- Rain Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$75.7M, a 47.3% decline from 2021.
- Rain Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$51.4M, a 144% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)